Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.
about
Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706The cholinergic hypothesis of Alzheimer's disease: a review of progressAlzheimer's disease as homeostatic responses to age-related myelin breakdownProgressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteinsRole of presenilin 1 in structural plasticity of cortical dendritic spines in vivoAlzheimer disease: new concepts on its neurobiology and the clinical role imaging will playPathways towards and away from Alzheimer's diseaseAmyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networksProtein phosphatases and Alzheimer's diseaseSynthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporterRosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neuronsNeurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's diseaseRegulation of the Postsynaptic Compartment of Excitatory Synapses by the Actin Cytoskeleton in Health and Its Disruption in DiseaseControl of Dendritic Spine Morphological and Functional Plasticity by Small GTPasesGetting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric OxideCalcium/calmodulin-dependent kinase II and Alzheimer's diseaseThe past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular eventsClearance systems in the brain-implications for Alzheimer diseaseAbnormal kalirin signaling in neuropsychiatric disorders.Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body diseaseMicroglial pathologyDisrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal modelsNeuropathological alterations in Alzheimer diseaseAmyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's diseaseAberrant insulin signaling in Alzheimer's disease: current knowledgeFingolimod for the treatment of neurological diseases-state of play and future perspectives3D in vitro modeling of the central nervous systemSynaptic dysfunction and septin protein family members in neurodegenerative diseasesAlzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.Entorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age.Correlative Light Electron Microscopy: Connecting Synaptic Structure and Function.Gulf War agent exposure causes impairment of long-term memory formation and neuropathological changes in a mouse model of Gulf War IllnessMultiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease miceHMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease.Interactions between Aβ oligomers and presynaptic cholinergic signaling: age-dependent effects on attentional capacitiesChronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's DiseaseThe Eye As a Biomarker for Alzheimer's DiseaseNeuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunitiesSynaptically released matrix metalloproteinase activity in control of structural plasticity and the cell surface distribution of GluA1-AMPA receptors
P2860
Q21129335-69169D88-128A-4F34-93B1-683E0407CB40Q22242019-0315E98C-3C60-40EA-8E7C-F380A16B9090Q22251261-F529A3CD-F663-4C14-84A5-AFC2181B926BQ24329069-334BA078-784C-4E23-BFAB-73EA955C0D8AQ24338802-7BE877D2-38A9-4AB2-97E4-E21827B13972Q24594531-3D1F6BF4-CCBA-45BC-9AB1-80A844F831F1Q24596270-8CD5B217-814A-4B48-97B2-C3326BBA6A2DQ24622558-A8226D84-5592-425F-8A5E-913CC430BF34Q24632495-5B529BB2-A585-4F30-8D06-13969F210898Q24650088-72A898AC-BD99-4BDC-9A08-AEAACDB77EEFQ24652687-99ABE49D-17BB-425E-B0D0-F1480632DE7BQ26741247-C7C060D6-84F6-4583-97B4-DCD06907B5B5Q26748973-8A97D2DA-C3FD-4617-8714-21C36F904645Q26753846-E1C42BAD-4DAB-4DA2-A0D9-6CA0C1CD4D6BQ26772294-82BD8F80-777C-46CA-A533-029B8489B8DAQ26776012-33118B72-7520-4F98-B903-62EB35DC4A90Q26781635-1D92BE13-C8D3-431E-B6CF-C8F575102445Q26801541-08527AD3-0D37-47B9-B704-961ED9E12C97Q26824648-5B2BF838-9B70-4FBF-8E09-0031C4C1E1B4Q26853610-B7DAA1DC-608A-4EB0-A934-92A1F3651590Q26992285-6DFB9808-57AA-4BD4-9CB5-31C9D9062DADQ26995918-274FED9C-2BBB-47FC-BCB1-DE4BA76A52D8Q27003314-897A3262-1CC6-4DCB-BC5F-79E82D811F3FQ27009411-26294E95-BC80-4C58-8659-53232EE7974BQ27024222-D7FEEBF1-ED58-4AAA-83A7-6EEEA5BF84D9Q27026175-1B35E193-EB06-4899-9952-4861E68340F6Q27026457-0F222EB6-A3F5-488C-BB4F-225D3E1A31D3Q27026829-5447194F-DAA5-4A2A-9C2C-6AFBB34820C8Q27303472-51B86DE1-D921-48A8-A92E-A2BFFB42EE6BQ27307826-EF30D6A4-0715-4A0D-91D9-5AF5B81D2A69Q27308708-51222FB2-AD67-4994-A697-C5AFAEA8651EQ27312033-092B9E55-483B-45C8-B973-A8CD311D3A2CQ27312360-25C68610-2273-4DE1-A872-53751CD9C167Q27315985-2F91BF81-CC67-4F9F-B0EE-A92F585514DBQ27331407-501F14DD-B6E3-461E-92F7-4F7C3E83E664Q27346441-257BABBD-D2D1-446E-9316-1E2234331D62Q28070142-6130D889-AB2D-4DF1-BEF7-42DA137C7F5AQ28070156-965448D8-D90E-43F2-90E1-A3C3836CED17Q28087158-95A46A53-DD2F-48E1-84F0-BE2A4DA2F012Q28539061-4BA86436-F631-458B-88BF-7522A33B9567
P2860
Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Synapse loss in frontal cortex ...... ation with cognitive severity.
@en
Synapse loss in frontal cortex ...... ation with cognitive severity.
@nl
type
label
Synapse loss in frontal cortex ...... ation with cognitive severity.
@en
Synapse loss in frontal cortex ...... ation with cognitive severity.
@nl
prefLabel
Synapse loss in frontal cortex ...... ation with cognitive severity.
@en
Synapse loss in frontal cortex ...... ation with cognitive severity.
@nl
P356
P1433
P1476
Synapse loss in frontal cortex ...... ation with cognitive severity.
@en
P2093
P304
P356
10.1002/ANA.410270502
P577
1990-05-01T00:00:00Z